Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)

NCT03046056 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gilead Sciences

Collaborators